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Convolutional neural network (CNN) methods have been pro-
posed to quantify lesions in medical imaging. Commonly more
than one imaging examination is available for a patient, but the
serial information in these images often remains unused. CNN-
based methods have the potential to extract valuable informa-
tion from previously acquired imaging to better quantify cur-
rent imaging of the same patient.
A pre-trained CNN can be updated with a patient’s previously
acquired imaging: patient-specific fine-tuning. In this work, we
studied the improvement in performance of lesion quantifica-
tion methods on MR images after fine-tuning compared to a
base CNN. We applied the method to two different approaches:
the detection of liver metastases and the segmentation of brain
white matter hyperintensities (WMH).
The patient-specific fine-tuned CNN has a better performance
than the base CNN. For the liver metastases, the median true
positive rate increases from 0.67 to 0.85. For the WMH segmen-
tation, the mean Dice similarity coefficient increases from 0.82
to 0.87. In this study we showed that patient-specific fine-tuning
has potential to improve the lesion quantification performance
of general CNNs by exploiting the patient’s previously acquired
imaging.
Correspondence: marielle@isi.uu.nl
Introduction
Lesion quantification is an important step in medical image
analysis. Over the years convolutional neural network (CNN)
based lesion quantification methods have been proposed for
medical images1–5 to aid radiologists in the detection and
segmentation of these lesions. For some diseases or treat-
ments, there is a clinical need to follow-up on the patient. For
these patients more than one imaging examination is avail-
able. The previously acquired scan, i.e. baseline scan, con-
tains patient-specific information that could be exploited by
the CNN-based method to better quantify the current scan of
the same patient, i.e. the follow-up scan.
The conventional way to train a CNN is to iterate over a large
data set representing the object to detect or segment. In this
way, a method is obtained that should give reliable results in
comparable data sets. However, CNN-based methods do not
always provide satisfying performance for clinical practice.
Differences in image quality and variations among patients
are often not fully covered within the method and can cause
insufficient results. As a result of training a CNN on a gen-
eral population, the CNN is not fully adapted to the specific
details of an individual patient.
Updating a CNN toward the features of a patient could im-
prove the outcome of the CNN for that specific patient6,7.
Previously acquired scans can be used for this purpose, as
they are already analyzed at the time of examination of the
follow-up scan. We therefore propose a method to enhance
the performance of lesion quantification in a follow-up scan
with a patient-specific fine-tuning approach. In addition, we
gained insight on the necessary conditions to achieve these
improvements.
Fine-tuning a pre-trained CNN has the benefit of obtaining
good results using only a small data set during the fine-tuning
step and has successfully been applied in previous studies.
For example, medical image domain knowledge has been
transferred to a CNN pre-trained on natural images by fine-
tuning the CNN with medical images8,9. Pre-trained CNNs
have been fine-tuned towards the features of one specific
image, resulting in better segmentations of that image10,11.
Patient-specific fine-tuning of a CNN is a method to update
the CNN using a previous scan of a patient. This fine-tuned
CNN has learned the specific features of abnormalities and
the surrounding healthy tissue to improve the detection or
segmentation in a follow-up scan. This approach is based
on the assumption that the baseline and follow-up scan of a
patient share the features of healthy tissue and abnormalities.
We present and evaluate the patient-specific fine-tuning ap-
proach on two applications; the detection of liver metastases
on MRI and the segmentation of brain white matter hyperin-
tensities (WMH) on MRI. Furthermore, different aspects of
patient-specific fine-tuning are studied.
Materials and methods
The proposed lesion quantification framework is shown in
Figure 1. First a CNN is trained using the training set, re-
ferred to as the base CNN model. Next, this base CNN is
refined for each individual patient in the patient-specific fine-
tuning step. A previous MRI scan of a patient, referred to as
baseline scan, is used to fine-tune the network to the specific
features of that patient and its lesions. During the testing step
this patient-specific CNN model is used to detect or segment
lesions in a follow-up MRI scan of the same patient. Two
MR sequences are applied to train and test the CNN model.
Data. The patient-specific fine-tuning approach is demon-
strated on two different data sets: abdominal MRI for liver
metastases detection and brain MRI for WMH segmentation.
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Fig. 1. Proposed lesion quantification framework, shown with the liver MRI. First a
base CNN is trained with a training set consisting of multiple patients. Next, the base
CNN is refined in the patient-specific fine-tuning step using a previous MRI exam
of a patient (the baseline scan). The fine-tuned CNN is used to detect or segment
lesions in a follow-up MRI scan of the same patient. The images are cropped to
focus of the organ of interest. The cropped image size is 128×128.
The UMCU Medical Ethical Committee has reviewed and
approved this study and informed consent was waived due to
its retrospective nature.
Liver metastases detection. In this study, abdominal MRI of
47 patients with liver metastases from the University Medical
Center Utrecht, the Netherlands, were included. Sixteen of
them had at least two consecutive MRI examinations within a
three months to a year. All patients underwent a clinical MRI
examination, including dynamic contrast enhanced (DCE)
MR series and diffusion weighted (DW) MRI, acquired on
a 1.5T scanner (Philips, Best, the Netherlands). These two
MR sequences are used to train the CNN.
The DCE-MR series was acquired in six breath holds with
one to five 3D images per breath hold, with in total 16 3D
images. The DW-MRI was acquired with three b-values: 10,
150, and 1000 s/mm2. The DCE-MRI was corrected for
motion using a principle component analysis (PCA) based
groupwise registration12. Intensity normalization was ap-
plied to both MR sequences and the DW-MRI was registered
to the DCE-MRI by a rigid transformation, followed by a b-
spline transformation (The parameter files used, are available
at elastix.bigr.nl/wiki/index.php/Par0057). The resulting im-
ages have 100 slices and matrix sizes of 256 × 256. Voxel
size is 1.543 mm × 1.543 mm × 2 mm.
The liver metastases were manually segmented on the DCE-
MRI by a radiologist in training and verified by a radiolo-
gist with more than ten years of experience. The data set in-
cluded mainly colorectal metastases, neuroendocrine metas-
tases, and some other metastasis types (i.e. other gastroin-
testinal metastases and breast metastases). On average 30%
of the liver slices contained liver metastases. Liver masks
were automatically obtained using our previously developed
segmentation method13.
MRI data from 31 patients of which only one MRI exam-
ination was available were used to train the base CNN. The
slices for training were limited to the slices containing metas-
tases for a more balanced data set, resulting in a total number
of 798 2D slices for training. The remaining 16 patients, with
available baseline and follow-up scans, were used for testing.
The scans had an average of 6 metastases per patient, ranging
from 1 to 31 metastases.
WMH segmentation. The brain MRI data of 80 memory clinic
patients with WMH were included in the study. Twenty of
the patients were from the Dutch Parelsnoer Institute - neu-
rodegenerative diseases study14, from the UMC Utrecht, the
Netherlands, and the remaining 60 were from the WMH chal-
lenge training set15. The 20 patients from UMC Utrecht had
two MRI examinations, with two years between the two ex-
aminations.
All MR exams were acquired with a similar protocol, with a
T2-weighted-Fluid-Attenuated Inversion Recovery (FLAIR)
MRI and a T1-weighted MRI, acquired on a 3T scanner16.
These two MR sequences are used to train the CNN. Both
MR sequences were bias field corrected and the T1-weighted
MRI were registered to the FLAIR images; more details can
be found in Kuijf et al.15. All images were resized to a matrix
size of 240 × 240 and 48 slices. Voxel size is 0.958 mm ×
0.958 mm × 3.00 mm.
The WMH were manually segmented on the FLAIR im-
ages by an experienced researcher, in accordance with the
STRIVE criteria17. WMH segmentation was performed with
in-house developed software on MeVisLab (MeVis Medical
Solutions AG, Bremen, Germany). On average 63% of the
brain slices contained WMH. Brain masks were obtained us-
ing the SPM software18. The MRI data of 60 patients with
a single MRI examination from the WMH challenge were
used for training. The slices for training were limited to the
slices containing WMH lesions for a more balanced data set,
resulting in a total of 1383 2D slices for training the base
CNN. The remaining 20 patients, with a baseline and follow-
up scan, were used for testing. These scans had an average of
65 WMH per patient, ranging from 21 to 117 WMH.
Base CNN model. The overall architecture of the CNN was
inspired by our earlier work on liver metastases detection13.
This fully convolutional architecture includes elements from
the P-net architecture, which has proven to be efficient for
updating10. As most MRI exams usually consist of multiple
MR sequences, we modified the original P-net to include a
dual pathway that can process two MR sequences, each in a
separate pathway to extract specific feature maps for those
sequences. The input image for each pathway was one MR
sequence. If the MR sequence had multiple instances, such
as the phases of the abdominal DCE-MRI, the 2D images
were combined into one input image with the instances as
channels. Variations on the network architecture have been
tested in our earlier work13. See Figure 2 for an overview of
the fully convolutional network architecture.
Each pathway had 13 convolutional layers (2 convolutional
layers and 11 dilated convolutional layers19 with varying di-
lation rates), each having 3×3 convolution and 64 kernels,
split in five blocks. The feature maps at the end of each block
of each pathway were concatenated in the third dimension,
resulting in a feature map with 640 kernels, and were passed
to two convolutional layers with a 1×1 convolution with 128
and 2 kernels, respectively. This resulted in a receptive field
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Fig. 2. Fully convolutional network architecture for lesion quantification. The blue
blocks represent the convolutional layers, batch normalization (BN) and ReLU or
softmax activation. The size of the kernel of each convolutional layer is given in
the block, followed by the number of kernels and the dilation rate of the kernel. The
dashed line indicates the trainable layers during the patient-specific fine-tuning step.
of 123×123 pixels.
During training, categorical cross-entropy was used as the
loss function. This loss function was calculated on a pixel
level resulting in detection by segmentation. ReLU activa-
tion and batch normalization were used in all the convolu-
tional layers, except for the final layer, which had a softmax
activation. Two dropout layers were applied before and after
the second-last layer. The dropout rate was set to 0.2. The
classes were weighted based on class frequencies. The class
weights were set to 1 for the background class and to 5 for the
lesion class. He uniform was used as initializer and Adam as
optimizer with a learning rate of 0.0001. The network was
trained for 10,000 iterations, with 4 images per mini batch.
Twenty-five patches of 128×128 pixels were taken from each
slice for data augmentation. The patches originated from the
organ of interest and have overlapping areas. Online data
augmentation was applied by random rotation of the patches,
with rotation angles of ±45 degrees.
Patient-specific fien-tuning. In the patient-specific fine-
tuning step the last two layers of the base CNN were fur-
ther trained with the baseline scan of a patient, to improve
the lesion quantification results in the follow-up scan of the
same patient. Only the last two layers were updated, as these
combine the feature maps of the previous blocks of the two
pathways and to ensure a fast fine-tuning step.
The CNN was refined by continuing training of the base CNN
with the weights of all layers frozen, i.e. untrainable, except
for those of the last two layers. The two trainable layers are
indicated with the dashed line box in Figure 2.
The same loss function, optimizer, and learning rate were
used as the ones during the training of the base CNN. The
CNN was refined with 4 images per mini batch and the num-
ber of iterations was optimized during the experiments, see
the Experiments section. The images used for fine-tuning
were MRI slices of the patient’s baseline scan. The baseline
scan was annotated earlier by an expert and only slices with
at least one lesion present were included in the fine-tuning
step. Five patches of 128×128 pixels were taken within the
organ of interest region from each slice, four patches from
the corners of the region and one center patch, removing air
and tissues not of interest from the input images. The patches
were randomly rotated, with rotation angles of ±45 degrees.
Rotation of the patches included the variance in the position-
ing of the body during the MRI examination.
Lesion quantification on follow-up scan. The follow-up
data was processed by the individual patient-specific CNN,
i.e. the base CNN fine-tuned with the baseline scan of that
patient. The probability output of the network was masked
by the liver or brain mask.
For the evaluation, the masked probability output was post-
processed to a binary image. A threshold of 0.5 was ap-
plied to the softmax output of the network and morphologi-
cal closing with a structuring element of 3×3×3 was applied
to fill holes. For the liver data set, the morphological closing
was followed by a morphological opening with a plus-shaped
structuring element of 3×3, to remove noise pixels. This was
not applied to the brain data set as WMHFF of 1 pixel occur
frequently. For the liver data set, the resulting binary im-
age was divided into separate objects representing individual
lesions, using voxel clustering with 26-neighbourhood con-
nection.
Experiments
The setup for the base CNN model and the process of fine-
tuning the CNN, as explained above, are similar for both the
liver metastases detection and the WMH segmentation. The
same experiments are conducted, only the evaluation is spec-
ified for the task: detection or segmentation.
Liver metastases detection. The detection of (new) liver
metastases is important to monitor disease progression and
for treatment planning. Treatment selection is based on the
detection findings, i.e. the location and the number of metas-
tases. Progress is monitored by follow-up scans.
The detection efficacy is evaluated using the true positive rate
(TPR), the number of false positives per case (FPC), and the
F1 score. As the values of the TPR, FPC, and F1 score do
not have a normal distribution, the median and interquartile
range (IQR) are reported and the Wilcoxon signed rank test
will be used to test for significant differences.
The TPR is calculated as the number of true positive ob-
jects divided by the total number of true lesion objects. A
lesion is considered detected, and thus a true positive ob-
ject, when the manual annotation and the predicted segmen-
tations have an overlap greater than 0. The FPC is cal-
culated as the number of detected objects not overlapping
with any true lesion object. The F1 score is calculated as
(2 ∗ recall ∗ precision)/(recall+ precision), where recall
is the TPR as defined above and precision is the number of
true positive objects divided by the total number of detected
objects (both true positive and false positive objects).
WMH segmentation. WMH are a common radiological
finding in the elderly population, and are generally con-
sidered to reflect cerebral small vessel disease.20 The pres-
ence and extent of WMH are associated with cognitive de-
cline and dementia.17,20,21 In particular, progression of WMH
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over time has been linked to cognitive decline and risk of
dementia.22,23 Quantification of WMH volume changes over
time could contribute to the monitoring of disease progres-
sion, and provide clinicians with relevant information for in-
formed decisions.
WMH segmentation on brain MRI is evaluated per MRI
exam using the overall Dice Similarity Coefficient (DSC)
and the absolute volume difference (AVD). The Dice score
is calculated as (2∗X ∩Y )/(X+Y ) , where X is the auto-
matic segmentation and Y the manual annotation. The AVD
is calculated as (abs(V (X)−V (Y )))/V (Y )∗100%, where
V (X) is the automatic segmentation volume and V (Y ) the
manual annotation volume. The mean and standard deviation
are reported and the paired Student’s t-test is used to test for
significant differences.
The following experiments study different elements of
patient-specific fine-tuning; the number of iterations, the
number of slices presented during fine-tuning, and a weight-
ing scheme.
Number of iterations. The duration of the fine-tuning
should be adapted to the similarity between the baseline and
the follow-up scan, as the baseline scan can have a differ-
ent appearance to the follow-up scan. For example, liver
metastases show changes in shape and size after treatment,
and WMH are known to progress from punctuate to conflu-
ent lesions over time. If the CNN is fine-tuned for too few
iterations the CNN will not be patient specific enough. If
the number of iterations is too high, the risk of overfitting to-
wards the baseline scan increases. The number of iterations is
therefore studied and the optimal number will be used in fur-
ther experiments. The number of iterations explored ranges
from 50 to 1000.
Number of slices. The possibility of fine-tuning with only
one or two slices is studied. Annotating or correcting the an-
notation of the baseline scan on one or two slices would be a
smaller effort than annotating a full image if a good annota-
tion does not yet exist. In these experiments, the number of
slices that are offered to the CNN are one, two, or all slices
with lesions or the full organ of interest present.
When not all slices are included, selection is based on the
softmax probability outcome of the base CNN on the base-
line scan. The slices with an average softmax probability
closest to 0.5 are selected, assuming that these slices contain
the most valuable information for updating the CNN. Two
options were explored for the slice selection procedure. The
first is including all slices for slice selection and the second
option is only including slices with lesions present for slice
selection.
Weighting. Weighting false negatives, false positives, and
true positives, obtained after performing the lesion quantifi-
cation with the base CNN on the baseline scan, will rede-
fine what we want the CNN to learn during fine-tuning. The
weights are set according the task to be performed.
For the detection task, the objective is to detect the metastases
on liver MRI. The weights of the missed metastases are set to
the highest value (five). The weights of the true positive pix-
els in detected metastases are set to two, with the weights of
false negatives and the false positive pixels connected to the
detected metastases set to zero. The background and false
positive objects weights are set to one. In this manner the
fine-tuned CNN will be greedier in labelling pixels as liver
metastasis. Over- or undersegmentation of detected metas-
tases is not considered incorrect labelling and false positive
objects are considered less problematic than missing a metas-
tasis.
For the segmentation task, the objective is to segment the
WMH on brain MRI and get a good lesion volume estima-
tion. The weights of the false positive and false negative pix-
els are set to the highest value (five), as the main goal is to
reduce the incorrectly labelled pixels. The weights of the true
positive pixels are set to two, and the true negative pixels are
set to one, to handle class imbalance.
The range of values of the weights are based on the class
weights during training of the base CNN, which were five
and one for lesions and background, respectively.
Uncertainty of CNN. The uncertainty of the CNN in detect-
ing or segmenting the lesions is assessed by the standard de-
viation (SD) in probability outcome of the softmax layer. We
implemented Monte Carlo dropout during test time24,25, re-
peating the test phase 25 times. The SD of the probabilities
over the 25 repetitions is calculated for every voxel. For the
detection task the mean SD of the detected metastases is cal-
culated as uncertainty metric, to study the change in network
uncertainty for detecting metastases. For the segmentation
task the maximum SD of all voxels in an image is taken as un-
certainty metric, to study the change in network uncertainty
for the entire image.
Results
Liver metastases detection.
Number of iterations. In Table 1 the TPR, FPC, and the F1
score are reported for different numbers of iterations during
the fine-tuning step. For a duration of only 50 iterations the
TPR is similar to the TPR of the base CNN, but for 100 iter-
ations and higher the TPR improves. However, for more than
50 iterations the FPC increases slightly. No significant dif-
ferences (Wilcoxon signed rank test with p<0.01) are found
between the base CNN and the fine-tuned CNN for differ-
ent number of iterations. For the remaining experiments, the
CNN is fine-tuned for 100 iterations.
Number of slices. The median [IQR] of the TPR, FPC, and
the F1 score for the inclusion of different (numbers of) slices
are presented in Table 2. The slice selection considered either
all liver slices or all slices containing metastases. The slices
with an average softmax probability closest to 0.5 were se-
lected. Including all the slices with liver metastases for fine-
tuning the CNN gives the best results for the liver metastases
detection method. Fine-tuning the CNN with only one or two
selected slices of the liver does not improve the results.
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Table 1. Median [interquartile range] of the true positive rate (TPR), the false pos-
itive count (FPC) and the F1 score of the liver metastases detection, for a varying
number of iterations (iter.) of learning for the CNN for fine-tuning. The best results
are printed in bold.
TPR FPC F1 Score
Base CNN 0.67 [0.32-1.00] 3 [0-7] 0.49 [0.21-0.67]
50 iter. 0.67 [0.20-1.00] 1 [0-3] 0.40 [0.25-0.80]
100 iter. 0.85 [0.44-1.00] 2 [0-3] 0.57 [0.40-0.67]
500 iter. 0.92 [0.33-1.00] 2 [0-4] 0.50 [0.25-0.71]
1000 iter. 0.85 [0.50-1.00] 1 [0-4] 0.50 [0.40-0.75]
Table 2. Median [interquartile range] of the true positive rate (TPR), the false pos-
itive count (FPC) and the F1 score for a ranging number of slices presented to the
CNN for fine-tuning. The best results are printed in bold. No significant differences
were found between the Base CNN and all options.
TPR FPC F1 Score
Base CNN 0.67 [0.32-1.00] 3 [0-7] 0.49 [0.21-0.67]
1 slice liver 0.50 [0.11-1.00] 4 [1-8] 0.33 [0.12-0.64]
2 slices liver 0.42 [0.11-1.00] 1 [0-5] 0.33 [0.15-0.67]
1 slice metas. 0.67 [0.08-1.00] 4 [2-6] 0.31 [0.00-0.50]
2 slices metas. 0.67 [0.08-1.00] 3 [1-5] 0.31 [0.00-0.44]
All metas.
slices 0.85 [0.44-1.00] 2 [0-3] 0.57 [0.40-0.67]
All liver slices 0.67 [0.20-1.00] 0 [0-3] 0.56 [0.33-0.80]
Weighting. The median [IQR] of the TPR, FPC and F1 score
for the base CNN, fine-tuned CNN without weights and fine-
tuned CNN with weights are presented in Table 3. The fine-
tuning was done for 100 iterations and included all metas-
tases slices. Putting more weight on the missed liver metas-
tases, leads to more detected metastases, but at the cost of
more false positive objects.
Qualitative results. Some visual examples of lesion detection
by the base CNN and by the patient-specific CNN are given
in Figure 3. The patient-specific CNN is fine-tuned in 100
iterations, including all slices with metastases present, and
without weights. After patient-specific fine-tuning the me-
dian TPR increases from 0.67 to 0.85, the median FPC de-
creases from 3 to 2, and the F1 score increases from 0.49 to
0.57.
Metastases smaller than 1.0 cm³ are more often missed by the
base CNN than larger metastases, an example of this can be
seen in the first column of Figure 3. The TPR for the small
metastases increases from 0.13 to 0.26 after patient-specific
fine-tuning, while the TPR of the large metastases only in-
Table 3. Median [interquartile range] of the true positive rate (TPR), the false pos-
itive count (FPC) and the F1 score of the liver metastases detection, for weighting
the true positives, false negatives and false positives during the patient-specific fine-
tuning (FT). The best results are printed in bold. An asterix indicates a significant
difference with results of the ‘Base CNN’ (Wilcoxon signed rank test with p<0.01).
TPR FPC F1 Score
Base CNN 0.67 [0.32-1.00] 3 [0-7] 0.49 [0.21-0.67]
FT CNN 0.85 [0.44-1.00] 2 [0-3] 0.57 [0.40-0.67]
Weighted
FT CNN 1.00 [0.62-1.00] 6 [3-14]
* 0.42 [0.29-0.57]
Fig. 3. Examples of the detection results of the base CNN and the patient-specific
CNN for three different patients. White outline = manual annotation, red outline
= false positive object, green check = detected metastasis, red cross = missed
metastasis.
creases slightly, from 0.81 to 0.83. The increase in TPR is
thus mainly due to the higher TPR of small metastases.
Uncertainty of CNN. The softmax probabilities of the de-
tected metastases by the base CNN have a mean SD of 0.203
(±0.078). The mean SD can be considered a measure of
the uncertainty of detection. The patient-specific CNN has
a mean of 0.158 (±0.070), which is significantly lower than
the mean SDs of the base CNN (p=0.003, paired Student’s
t-test). The patient-specific CNN does not only detect more
metastases, it is also more certain about the detected metas-
tases.
WMH segmentation.
Number of iterations. All four options (50, 100, 500, or 100
iterations) for the duration of the fine-tuning, give similar re-
sults. The Dice score significantly increases (Paired Student’s
t-test with p<0.01) and the AVD decreases after fine-tuning in
comparison with the results of the base CNN. The base CNN
has a mean DSC of 0.82 and a mean AVD of 20.7%. The
fine-tuned CNNs have a mean DSC around 0.87 and a mean
AVD around 10%. Using only 50 iterations gives a slightly
lower Dice score (0.85) than the higher number of iterations.
The number of iterations is set to 100 for the rest of the ex-
periments.
Number of slices. The mean (± SD) of the Dice score and the
AVD for different numbers of slices are presented in Table 4.
The slice selection method selected the same slices when ei-
ther all brain slices or all WMH slices were considered for
selection. The selected slices originated mostly from the area
around the ventricles and the regions with large WMH. In-
cluding one slice already alters the Dice score and the AVD
significantly. Meanwhile, further inclusion of all lesion or
brain slices gives only a slightly better result. It is therefore
possible to only annotate the one or two selected slices and
improve the segmentation using these slices in the fine-tuning
process.
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Table 4. Mean (±SD) of the Dice score and absolute volume difference (AVD) of
the WMH segmentation for a varying number of slices for fine-tuning. The best
results are printed in bold. A cross indicates a significant difference with results of
the ‘Base CNN’ (Paired Student’s t-test with p<0.01).
Dice score AVD (%)
Base CNN 0.82 ± 0.05 20.7 ± 13.5
1 slice 0.86 ± 0.04† 11.2 ± 8.2
2 slices 0.86 ± 0.04† 10.7 ± 7.9
All lesion slices 0.87 ± 0.04† 10.7 ± 7.3
All brain slices 0.87 ± 0.04† 10.2 ± 6.9†
Table 5. Mean (±SD) of the Dice score and absolute volume difference (AVD) of
the WMH segmentation for weighting the true positives, false negatives and false
positives during the patient-specific fine-tuning (FT). The best results are printed
in bold. A cross indicates a significant difference with results of the ‘Base CNN’
(Paired Student’s t-test with p<0.01).
Dice score AVD (%)
Base CNN 0.82 ± 0.05 20.7 ± 13.5
FT CNN 0.87 ± 0.04† 10.7 ± 7.3
Weighted FT CNN 0.86 ± 0.05† 11.8 ± 10.5
Weighting. In Table 5 the mean (± SD) of the Dice score and
the AVD are presented for the base CNN, fine-tuned CNN
without weights and fine-tuned CNN with weights. Visual
inspection of the results showed that weighting the true posi-
tive, false positive, and false negative pixels makes the CNN
more prone to label a pixel as lesion, resulting in oversegmen-
tation. For the WMH lesion segmentation task weighting the
pixels did not result in a better segmentation.
Qualitative results. Some visual examples of the lesion seg-
mentation on the follow-up scan by the base CNN and the
patient-specific CNN are given in Figure 4. The patient-
specific CNN is fine-tuned in 100 iterations, including all
slices with WMH lesions present, and without weights. After
patient-specific fine-tuning the average Dice score increases
from 0.82 to 0.87, the AVD decreases from 20.7% to 10.7%.
Other metrics of evaluation in the WMH challenge are the
modified Hausdorff distance, TPR, and F1 score15. After
patient-specific fine-tuning the Hausdorff distance decreases
from 2.40 mm to 2.01 mm, the TPR decreases from 0.84 to
0.63, and the F1 score remains 0.72. The TPR decreases, be-
cause the fine-tuned CNN misses lesions with the size of only
a few pixels. However, the other metrics improve due to the
decrease in false positives and better volume segmentation.
The majority of the incorrectly labelled pixels by the base
CNN are either small false positive regions (e.g. see Fig-
ure 4, second column) or false negative pixels as part of
larger lesions (e.g. see Figure 4, first column). The patient-
specific CNN learns to label these pixels correctly, resulting
in a higher Dice score and lower AVD and thus providing a
better WMH segmentation.
Smaller lesions are harder to segment than larger lesions15
and we noticed that the patient-specific CNN missed more
smaller lesions (<0.01 cm³) than the base CNN in the seg-
mentation, but at the same time also segmented fewer false
positive pixels. The lesions and (noisy) false positive pixels
Fig. 4. Examples of the follow-up scan with the segmentation results of the base
CNN and the patient-specific CNN for three different patients. Green = true positive
pixels, red = false negative pixels, and blue = false positive pixels.
Fig. 5. An example of the uncertainty (SD of softmax probability) of the base CNN
and the patient-specific CNN. A high SD means the CNN is uncertain about its
decision.
labelled by the base CNN have a similar appearance, result-
ing in either labelling them all as lesion or all as background.
The fine-tuning procedure seems to put more emphasis on re-
ducing the smallest false positives, at the cost of small false
negatives. Figure 4, column 3 shows an example of these
mislabeled pixels representing small lesions.
Uncertainty of CNN. The softmax probabilities of the base
CNN have a mean maximum SD of 0.398 (±0.025). The
patient-specific CNN has a mean maximum SD of 0.328
(±0.038), which is significantly lower than the maximum
SDs of the base CNN (p<0.001, paired Student’s t-test). In
Figure 5, an example is given of the mapped SD of the prob-
abilities. The patient-specific CNN is more certain about the
labels given, especially within large WMH.
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Discussion
Patient-specific fine-tuning of a CNN with previously ac-
quired MR images yields improvements for quantification of
lesions on subsequent MR images. The true positive rate
for the detection of liver metastases and the Dice score for
the WMH segmentation both increase after patient-specific
fine-tuning. Additionally, the certainty of the patient-specific
CNN is higher than the certainty of the base CNN.
This study shows the potential of the patient-specific fine-
tuning step to improve lesion quantification results when
follow-up imaging assessment is performed. Previously ac-
quired scans of a patient are proven to hold valuable infor-
mation to refine a CNN accordingly, resulting in a better per-
formance. The patient-specific fine-tuning step increases the
lesion quantification effectiveness for two applications and
we expect other applications to benefit from this fine-tuning
step as well.
The loss function used is not tailored towards the detection of
liver metastases but rather to the segmentation of the metas-
tases. In case of large over- or undersegmentation on the
baseline scan, it is most cost-effective for the CNN to cor-
rect those areas. Large false positive regions are caused by
tissue appearances the base CNN is not familiar with, such as
radiofrequency ablation (RFA) regions in the liver from ear-
lier treatments. The patient-specific CNN will learn to cor-
rectly label the majority of the pixels in these regions. How-
ever, after patient-specific fine-tuning pixels with a similar
appearance, but of the other class, can be labeled incorrectly.
This is an overshoot on the follow-up scan, where the patient-
specific CNN corrects its results too much. False negatives
on the baseline then might cause some false positives on the
follow-up due to a similar appearance and vice versa. As a
consequence, more objects are detected incorrectly or more
are missed, respectively. This might be overcome by tailor-
ing the loss function towards the detection task, i.e. calculate
the loss function on an object base instead of pixel base.
The patient-specific fine-tuning method assumes that the
baseline and follow-up scan share features that describe the
lesions and healthy tissue. However, there can be differences
between the baseline scan and the follow-up scan due to (on-
going) treatment and image quality variations. The patients
in the brain data set did not undergo any treatment that would
be expected to influence WMH features, while most patients
in the liver data set did. Therefore, the liver data set shows vi-
sually more differences between the consecutive MRI scans
than the brain data set. Variation in consecutive images in-
creases the risk of overfitting when the CNN is fine-tuned for
many iterations. In addition, fine-tuning for more than 100
iterations did not improve the results compared to fine-tuning
for 100 iterations.
Regarding the number of slices to include in the fine-tuning
step, both applications yielded the best results when includ-
ing all slices with lesions present. However, for the WMH
segmentation including one or two slices gave similar results.
The WMH have similar features throughout the slices and the
consecutive MRI exams. This resemblance makes it possible
to fine-tune the CNN with only one or two slices, reducing
the time and effort invested in annotating the slices. The liver
metastases have different features throughout the slices and
MRI exams, requiring to fine-tune the CNN with all metas-
tases slices.
In addition, an imbalanced data set arises for the liver metas-
tases detection when all the liver slices are included in the
fine-tuning step. That is, on average only 30% of the liver
slices contain liver metastases, while 63% of the brain slices
contain WMH. The CNN will then learn to distinguish dif-
ferent types of background instead of the appearance of liver
metastases, leading to fewer false positives and unfortunately
also fewer true positives. In case of an imbalanced data
set, a full lesion annotation is necessary to include only
the slices with lesions present and gain improvement with
patient-specific fine-tuning. In other cases annotations of a
selection of slices might be sufficient to gain improvement
on lesion quantification.
Moreover, the difference in the percentage of slices contain-
ing lesions leads to a considerable difference in the chance
that a slice with lesions is selected. This resulted in the se-
lection of slices without liver metastases and the unsuccess-
ful fine-tuning of the CNN. Since brain MRI contain more
slices with WMH, the chance to automatically select slices
with WMH present is higher, resulting in a successful fine-
tuning of the CNN.
Weighting the true positives and false positives makes the de-
tection CNN more inclined to label a pixel as lesion. This
results in more detected lesions, but also more false posi-
tives in comparison with the non-weighted patient-specific
CNN. Considering the aim of the detection one might allow
more false positive objects in order for more detected lesions.
However for the WMH segmentation, the weighting of the
false positives, false negatives, and true positive pixels did
not result in a better segmentation.
The information about the location of the lesions found in
the baseline scan could be a valuable information for the de-
tection method. At the moment only the appearances of the
lesion and non-lesion tissue are learned. Adding the spatial
information of former lesions could aid the method in finding
formerly existing lesions. Image registration could be used
to detect these lesions in follow-up scans. However such a
method should also take into account that more lesions can
develop or that lesions can disappear due to treatment.
Conclusions
In conclusion, patient-specific fine-tuning of a CNN for the
quantification of lesions is a viable option to enhance the per-
formance of the method using previously acquired data of
the same patient. The CNN is fine-tuned towards the features
specific for that patient resulting in a better performance of
the CNN. It is important that slices with lesions that represent
the features of all lesions are included in the patient-specific
fine-tuning step, as well as avoiding imbalanced classes in
these slices. In doing so, the patient-specific CNN detected
more liver metastases than the base CNN, with the true pos-
itive rate increasing from 0.67 to 0.85. The patient-specific
CNN segments the WMH better than the base CNN with the
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Dice score increasing from 0.82 to 0.87.
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